Search research articles
Contact Us
Filters
Showing results (111-120 of 175) with videos related to
Page
of 18
Sort By:
International Journal of Antimicrobial Agents
|
July 22, 2021
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy
Roberta Gagliardini, Nicola Gianotti, Franco Maggiolo, et al.
The New Microbiologica
|
December 20, 2022
Early Diagnosis and Linkage to Care: an Experience over 14 years of Point of Care Rapid HIV Testing
Angelo Roberto Raccagni, Laura Soldini, Silvia Nozza, et al.
International Journal of STD & AIDS
|
January 9, 2025
Emerging sexually transmitted infections outbreak: Dermatophytosis among men who have sex with men in Milan, Italy
Chiara Maci, Angelo Roberto Raccagni, Riccardo Lolatto, et al.
Open Forum Infectious Diseases
|
November 5, 2024
Breakthrough Rectal <i>Neisseria gonorrhoeae</i> Infections After Meningococcal B Vaccination: Microbiological and Clinical Features
Angelo Roberto Raccagni, Sara Diotallevi, Riccardo Lolatto, et al.
Blood
|
August 15, 2002
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
Mauro Malnati, Francesco Broccolo, Silvia Nozza, et al.
Journal of Medical Virology
|
June 15, 2019
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection
Andrea Giacomelli, Massimiliano Fabbiani, Ilaria De Benedetto, et al.
Microorganisms
|
February 24, 2024
Systematic Review: Strategies for Improving HIV Testing and Detection Rates in European Hospitals
Klaske J Vliegenthart-Jongbloed, Marta Vasylyev, Carlijn C E Jordans, et al.
Sexually Transmitted Diseases
|
April 22, 2024
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort
Maria Francesca Lucente, Angelo Roberto Raccagni, Laura Galli, et al.
Journal of the International AIDS Society
|
November 15, 2014
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
Drug Design, Development and Therapy
|
July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
Martina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 175) with videos related to
Sort By:
Page
of 18
International Journal of Antimicrobial Agents
|
July 22, 2021
Durability of rilpivirine-based versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy
Roberta Gagliardini, Nicola Gianotti, Franco Maggiolo, et al.
The New Microbiologica
|
December 20, 2022
Early Diagnosis and Linkage to Care: an Experience over 14 years of Point of Care Rapid HIV Testing
Angelo Roberto Raccagni, Laura Soldini, Silvia Nozza, et al.
International Journal of STD & AIDS
|
January 9, 2025
Emerging sexually transmitted infections outbreak: Dermatophytosis among men who have sex with men in Milan, Italy
Chiara Maci, Angelo Roberto Raccagni, Riccardo Lolatto, et al.
Open Forum Infectious Diseases
|
November 5, 2024
Breakthrough Rectal <i>Neisseria gonorrhoeae</i> Infections After Meningococcal B Vaccination: Microbiological and Clinical Features
Angelo Roberto Raccagni, Sara Diotallevi, Riccardo Lolatto, et al.
Blood
|
August 15, 2002
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy
Mauro Malnati, Francesco Broccolo, Silvia Nozza, et al.
Journal of Medical Virology
|
June 15, 2019
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection
Andrea Giacomelli, Massimiliano Fabbiani, Ilaria De Benedetto, et al.
Microorganisms
|
February 24, 2024
Systematic Review: Strategies for Improving HIV Testing and Detection Rates in European Hospitals
Klaske J Vliegenthart-Jongbloed, Marta Vasylyev, Carlijn C E Jordans, et al.
Sexually Transmitted Diseases
|
April 22, 2024
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort
Maria Francesca Lucente, Angelo Roberto Raccagni, Laura Galli, et al.
Journal of the International AIDS Society
|
November 15, 2014
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting
Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
Drug Design, Development and Therapy
|
July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
Martina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Page
of 18